{
    "title": "Individual feed for https://www.cnbc.com/id/15839135/device/rss/rss.html",
    "link": "https://www.cnbc.com/id/15839135/device/rss/rss.html",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-02-06T07:51:47.596334",
    "items": [
        {
            "title": "MicroStrategy unveils new name, reports accelerated bitcoin purchases in fourth quarter",
            "link": "https://www.cnbc.com/2025/02/05/microstrategy-unveils-new-name-reports-accelerated-bitcoin-purchases-in-fourth-quarter.html",
            "description": "The largest corporate holder of bitcoin said it's almost halfway to its $42 billion capital-raising goal after it went on a buying spree last quarter.",
            "pubDate": "2025-02-06T12:51:15",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png"
        },
        {
            "title": "Strong Taco Bell sales fuel Yum Brands earnings beat",
            "link": "https://www.cnbc.com/2025/02/06/yum-brands-yum-earnings-q4-2024.html",
            "description": "Taco Bell owner Yum Brands beat Wall Street's earnings and revenue estimates.",
            "pubDate": "2025-02-06T12:40:53",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png"
        },
        {
            "title": "Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars",
            "link": "https://www.cnbc.com/2025/02/06/eli-lilly-lly-earnings-q4-2024.html",
            "description": "The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.",
            "pubDate": "2025-02-06T12:21:03",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "Peloton posts better than expected holiday sales thanks in part to Costco",
            "link": "https://www.cnbc.com/2025/02/06/peloton-pton-q2-2025-earnings.html",
            "description": "Peloton has shifted its focus to boosting profitability at the expense of growing sales by cutting marketing and other administraitive costs.",
            "pubDate": "2025-02-06T12:17:21",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance",
            "link": "https://www.cnbc.com/2025/02/06/bristol-myers-squibb-bmy-earnings-q4-2024.html",
            "description": "The company also issued a 2025 guidance that fell short of expectations, as some of the company's older drugs face competition from cheaper generics.",
            "pubDate": "2025-02-06T12:01:06",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        }
    ]
}